NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Liberal Transfusion Strategy in Elderly Patients
Liberal Transfusion Strategy in Elderly Patients

NCT03369210

CompletedPhase 3

Sponsor: Johann Wolfgang Goethe University Hospital

Conditions: Transfusion-dependent Anemia, Surgery, Anemia

Interventions: red blood cell transfusion trigger

Countries: Germany

In this prospective, multicentre, open, randomised, controlled clinical trial elderly patients (≥ 70 years) undergoing intermediate- or high-risk non-cardiac surgery will be randomised either to a liberal group (patients receive a RBC unit each time Hb falls ≤ 9 g/dl (≤ 5.6mmol/l) with a target range for the post-transfusion Hb level of 9-10.5 g/dl (5.6-6.5 mmol/l)) or restrictive group (patients receive a single RBC unit each time Hb falls ≤ 7.5 g/dl (≤ 4.7 mmol/l) with a target range for the post-transfusion Hb level of 7.5-9 g/dl (4.7-5.6 mmol/l). Primary efficacy endpoint: is a composite of death from any cause and anaemia-associated, ischaemic events (defined as acute myocardial infarction, acute ischaemic stroke, acute kidney injury stage III, acute mesenteric ischaemia, acute peripheral vascular ischaemia) within 90 days after surgery.

Eligibility overview

Sex: ALL

Age: 70 Years to

Healthy volunteers: No

Study type: INTERVENTIONAL

Eligibility criteria
Inclusion Criteria:

* Patients ≥ 70 years of age scheduled for intermediate- or high-risk non-cardiac surgery will be registered
* Registered patients will be randomised only if they indeed develop severe anaemia (if Hb level falls ≤ 9 g/dl) during surgery (=day 0) or day 1, 2, or 3 after surgery

Exclusion Criteria:

* preoperative Hb level ≤ 9 g/dl
* chronic kidney disease requiring dialysis
* suspected lack of compliance with follow-up procedures
* participation in other interventional trials
* expected death within 3 months
* inability to provide informed consent with absence of a legally authorised representative/ legal guardian
* temporary inability to provide informed consent
* previous participation in our trial
* patients who are prevented from having blood and blood products according to a system of beliefs (e.g. Jehovah's Witnesses)
* preoperative autologous blood donation.
Locations (17)
  • Aachen, Germany
  • Augsburg, Germany
  • Berlin, Germany
  • Berlin, Germany
  • Bonn, Germany
  • Dortmund, Germany
  • Frankfurt, Germany
  • Giessen, Germany
  • Greifswald, Germany
  • Hamburg, Germany
  • Jena, Germany
  • Kiel, Germany
  • Mainz, Germany
  • Münster, Germany
  • Münster, Germany
  • Regensburg, Germany
  • Würzburg, Germany